Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
University of Pennsylvania
Study ID
NCT05865054
Status
Recruiting
Apply to this trial

Conditions

  • Giant Cell Arteritis

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Magnetic Resonance Imaging (MRI) — DIAGNOSTIC_TEST
    Combined orbital and cranial vessel wall MRI

Study Details

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Key Dates

Start date
Jul 29, 2020
Status verified
Sep 2025
Primary completion
Jul 31, 2030
Completion
Jul 31, 2033

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Ocular GCA
    GCA with clinical diagnosis of ischemic optic neuropathy or other ocular condition
  • Arm: Non-Ocular GCA
    GCA without ocular manifestations
  • Arm: Non-GCA
    Initially suspected to have GCA but final clinical diagnosis not GCA

Primary Outcome Measure

Vessel Wall Enhancement Score [ Time Frame: Up to 12 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo Building and Gonda BuildingRochesterMinnesota55905
Jennifer Sletten
[email protected]
507-284-3695
3400 Civic Center BlvdPhiladelphiaPennsylvania19104
Brenda Hernandez-Romero, B.S
[email protected]
917-548-2067
Rennie Rhee, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Building and Gonda Building· Rochester, MN3400 Civic Center Blvd· Philadelphia, PA

Related Studies